Human MIF Antibody Summary
Pro2-Ala115
Accession # P14174
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human MIF by Western Blot. Western blot shows lysate of K562 human chronic myelogenous leukemia cell line. PVDF membrane was probed with 1 µg/mL of Mouse Anti-Human MIF Monoclonal Antibody (Catalog # MAB289) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for MIF at approximately 12 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Humean MIF by Simple WesternTM. Simple Western lane view shows lysates of THP‑1 human acute monocytic leukemia cell line and U937 human histiocytic lymphoma cell line, loaded at 0.2 mg/mL. A specific band was detected for MIF at approximately 12 kDa (as indicated) using 10 µg/mL of Mouse Anti-Human MIF Monoclonal Antibody (Catalog # MAB289). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: MIF
MIF (or macrophage migration inhibitory factor) was the first lymphokine/cytokine to be recognized in the pregenomics era (1, 2). Regardless, it is one of the least understood of all inflammatory mediators (1, 3). Human MIF is a 12.5 kDa, 115 amino acid (aa) nonglycosylated polypeptide that is synthesized without a signal sequence (4-7). Secretion occurs nonclassically via an ABCA1 transporter (8). The initiating Met is removed, leaving Pro as the first amino acid. The molecule consists of two alpha -helices and six beta -strands, four of which form a beta -sheet. The two remaining beta -strands interact with other MIF molecules, creating a trimer (2, 9, 10). Structure-function studies suggest MIF is bifunctional with segregated topology. The N- and C-termini mediate enzyme activity (in theory). Phenylpyruvate tautomerase activity (enol-to-keto) has been demonstrated and is dependent upon Pro at position #1 (11). Amino acids 50-65 have also been suggested to contain thiol-protein oxidoreductase activity (12). MIF has proinflammatory cytokine activity centered around aa’s 49-65. On fibroblasts, MIF induces, IL-1, IL-8, and MMP expression; on macrophages, MIF stimulates NO production and TNF-alpha release following IFN-gamma activation (13, 14). MIF apparently acts through CD74 and CD44, likely in some form of trimeric interaction (15, 16). Human MIF is active on mouse cells (14). Human MIF is 90%, 94%, 95%, and 90% aa identical to mouse, bovine, porcine, and rat MIF, respectively.
- Norand, E.F. and M. Leech (2005) Front. Biosci. 10:12.
- Donn, R.P. and D.W. Ray (2004) J. Endocrinol. 182:1.
- Calandra, T. and T. Roger (2003) Nat. Rev. Immunol. 3:791.
- Kozak, C.A. et al. (1995) Genomics 27:405.
- Weiser, W.Y. et al. (1989) Proc. Natl. Acad. Sci. USA 86:7522.
- Paralkar, V. and G. Wistow (1994) Genomics 19:48.
- Wistow, G.J. et al. (1993) Proc. Natl. Acad. Sci. USA 90:1272.
- Flieger, O. et al. (2003) FEBS Lett. 551:78.
- Philo, J.S. et al. (2004) Biophys. Chem. 108:77.
- Sun, H-W. et al. (1996) Protein Eng. 9:631.
- Stamps, S.L. et. al. (2000) Biochemistry 39:9671.
- Nguyen, M.T. et al. (2003) J. Biol. Chem. 278:33654.
- Sato, A. et al. (2003) Dev. Comp. Immunol. 27:401.
- Bernhagen, J. et al. (1994) Biochemistry 33:14144.
- Leng, L. et al. (2003) J. Exp. Med. 197:1467.
- Meyer-Siegler, K.L. and P.L. Vera (2005) J. Urol. 173:615.
Product Datasheets
Citations for Human MIF Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
17
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers
Authors: GF Jang, JS Crabb, B Hu, B Willard, H Kalirai, AD Singh, SE Coupland, JW Crabb
Cancers, 2021-07-14;13(14):.
Species: Human
Sample Types: Tissue Homogenates
Applications: Western Blot -
Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
Authors: HA Oh, J Kwak, BJ Kim, HJ Jin, WS Park, SJ Choi, W Oh, S Um
Cells, 2020-05-28;9(6):.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
Authors: W Ha, H Sevim-Nalk, AM Zaman, K Matsuda, M Khasraw, AK Nowak, L Chung, RC Baxter, KL McDonald
Sci Rep, 2019-02-27;9(1):2905.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea
Authors: JS Kim, J Choi, HJ Hahn, YB Lee, DS Yu, JW Kim
PLoS ONE, 2016-09-06;11(9):e0162477.
Species: Human
Sample Types: Plasma
Applications: ELISA Development (Capture) -
Macrophage Migration Inhibitory Factor in Acute Adipose Tissue Inflammation.
Authors: Kim B, Rongisch R, Hager S, Grieb G, Nourbakhsh M, Rennekampff H, Bucala R, Bernhagen J, Pallua N
PLoS ONE, 2015-09-08;10(9):e0137366.
Species: Human
Sample Types: Tissue Homogenates, Whole Tissue
Applications: ELISA Development (Capture), IHC-P -
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
Authors: Crabb J, Hu B, Crabb J, Triozzi P, Saunthararajah Y, Tubbs R, Singh A
PLoS ONE, 2015-08-25;10(8):e0135543.
Species: Human
Sample Types: Tissue Homogenates
Applications: Western Blot -
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Authors: Oliveira, Camila S, de Bock, Charles, Molloy, Timothy, Sadeqzadeh, Elham, Geng, Xin Yan, Hersey, Peter, Zhang, Xu Dong, Thorne, Rick F
BMC Cancer, 2014-08-29;14(0):630.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
A multiplex immunoassay for human adipokine profiling.
Authors: Schipper HS, De Jager W, van Dijk ME, Meerding J, Zelissen PM, Adan RA, Prakken BJ, Kalkhoven E
Clin. Chem., 2010-06-08;56(0):1320.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Luminex Development -
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Authors: Ren Y, Law S, Huang X, Lee PY, Bacher M, Srivastava G, Wong J
Ann. Surg., 2005-07-01;242(1):55-63.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium.
Authors: Wadgaonkar R, Dudek SM, Zaiman AL, Linz-McGillem L, Verin AD, Nurmukhambetova S, Romer LH, Garcia JG
J. Cell. Biochem., 2005-07-01;95(4):849-58.
Species: Bovine, Human
Sample Types: Cell Lysates
Applications: Immunoprecipitation -
Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis.
Authors: Ren Y, Lin CL, Li Z, Chen XY, Huang X, Lui V, Nicholls J, Lan HY, Tam PK
Histopathology, 2005-06-01;46(6):659-67.
Species: Human
Sample Types: Serum
Applications: Neutralization -
Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
Authors: Matsumoto K, Maruyama N, Maruyama T, Ohnishi Y, Nonaka S, Inoshita A, Ito K, Kitajima S, Abe M, Satomura A, Fujita T
Clin. Exp. Immunol., 2005-02-01;139(2):338-47.
Species: Human
Sample Types: Urine, Whole Tissue
Applications: ELISA Development, IHC -
Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.
Authors: Riedemann NC, Guo RF, Gao H, Sun L, Hoesel M, Hollmann TJ, Wetsel RA, Zetoune FS, Ward PA
J. Immunol., 2004-07-15;173(2):1355-9.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor?
Authors: Chuang CC, Hung CJ, Tsai MC, Chuang YC
Crit. Care Med., 2004-03-01;32(3):734-9.
Species: Human
Sample Types: Serum
Applications: ELISA Development -
Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor.
Authors: Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, Burow M, Horan MA, Wahl SM, Nakayama T
J. Clin. Invest., 2003-05-01;111(9):1309-18.
Species: Mouse
Sample Types: Cell Culture Supernates
Applications: ELISA Development -
Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.
Authors: Matsumoto K, 2019, Kanmatsuse K
7587, 2002-10-01;92(2):309-15.
Species: Human
Sample Types: Urine
Applications: ELISA Development -
Human V gamma 2V delta 2 T cells augment migration-inhibitory factor secretion and counteract the inhibitory effect of glucocorticoids on IL-1 beta and TNF-alpha production.
Authors: Wang L, Das H, Kamath A, Li L, Bukowski JF
J. Immunol., 2002-05-15;168(10):4889-96.
Species: Human
Sample Types: Cell Culture Supernates
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human MIF Antibody
Average Rating: 4.2 (Based on 6 Reviews)
Have you used Human MIF Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: